Refine Search
(16)
(34)
(74)
(75)

Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Human Papillomavirus (HPV) Associated Cancer - Pipeline Review, H2 2018’, provides an overview of the Human Papillomavirus (HPV) Associated Cancer pipeline landscape.

The report provides comprehensive informatio...

Head And Neck Cancer - Pipeline Review, H2 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H2 2018’, provides an overview of the Head And Neck Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Head...

Gastric Cancer - Pipeline Review, H2 2018

  • $2,500
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H2 2018’, provides an overview of the Gastric Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gastric Cancer, ...

Bone Metastasis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bone Metastasis - Pipeline Review, H2 2018’, provides an overview of the Bone Metastasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bone Metastasi...

Fallopian Tube Cancer - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H2 2018’, provides an overview of the Fallopian Tube Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fa...

Oropharyngeal Cancer - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Oropharyngeal Cancer - Pipeline Review, H2 2018’, provides an overview of the Oropharyngeal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Orop...

Peritoneal Cancer - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Peritoneal Cancer - Pipeline Review, H2 2018’, provides an overview of the Peritoneal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Peritoneal...

Pheochromocytoma - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pheochromocytoma - Pipeline Review, H2 2018’, provides an overview of the Pheochromocytoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pheochromocy...

Essential Thrombocythemia - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Essential Thrombocythemia - Pipeline Review, H2 2018’, provides an overview of the Essential Thrombocythemia pipeline landscape.

The report provides comprehensive information on the therapeutics under developmen...

Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2018’, provides an overview of the Basal Cell Carcinoma (Basal Cell Epithelioma) pipeline landscape.

The report provides comprehensive informat...

Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Adrenocortical Carcinoma (Adrenal Cortex Cancer) - Pipeline Review, H2 2018’, provides an overview of the Adrenocortical Carcinoma (Adrenal Cortex Cancer) pipeline landscape.

The report provides comprehensive in...

Retinoblastoma - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Retinoblastoma - Pipeline Review, H2 2018’, provides an overview of the Retinoblastoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Retinoblastoma, ...

Rhabdomyosarcoma - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rhabdomyosarcoma - Pipeline Review, H2 2018’, provides an overview of the Rhabdomyosarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rhabdomyosar...

Hairy Cell Leukemia - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hairy Cell Leukemia - Pipeline Review, H2 2018’, provides an overview of the Hairy Cell Leukemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hairy ...

Ureter Cancer - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ureter Cancer - Pipeline Review, H2 2018’, provides an overview of the Ureter Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ureter Cancer, com...

Uveal Melanoma - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Uveal Melanoma - Pipeline Review, H2 2018’, provides an overview of the Uveal Melanoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Uveal Melanoma, ...

Oligodendroglioma - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H2 2018’, provides an overview of the Oligodendroglioma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Oligodendr...

Thyroid Cancer - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Thyroid Cancer - Pipeline Review, H2 2018’, provides an overview of the Thyroid Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Thyroid Cancer, ...

Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cancer Anorexia-Cachexia Syndrome - Pipeline Review, H2 2018’, provides an overview of the Cancer Anorexia-Cachexia Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Esophageal Cancer - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H2 2018’, provides an overview of the Esophageal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Esophageal...

Malignant Mesothelioma - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H2 2018’, provides an overview of the Malignant Mesothelioma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Ependymoma - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ependymoma - Pipeline Review, H2 2018’, provides an overview of the Ependymoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ependymoma, complete wit...

Hypopharyngeal Cancer - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hypopharyngeal Cancer - Pipeline Review, H2 2018’, provides an overview of the Hypopharyngeal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hy...

Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H2 2018’, provides an overview of the Post-Polycythemia Vera Myelofibrosis (PPV-MF) pipeline landscape.

The report provides comprehensive informat...

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2018’, provides an overview of the Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) pipeline landscape.

The report provides comprehensive information on...

Polycythemia Vera - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Polycythemia Vera - Pipeline Review, H2 2018’, provides an overview of the Polycythemia Vera pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Polycythem...

Anal Cancer - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Anal Cancer - Pipeline Review, H2 2018’, provides an overview of the Anal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Anal Cancer, complete ...

Osteosarcoma - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteosarcoma - Pipeline Review, H2 2018’, provides an overview of the Osteosarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteosarcoma, comple...

Rectal Cancer - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Rectal Cancer - Pipeline Review, H2 2018’, provides an overview of the Rectal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Rectal Cancer, com...

Nasopharyngeal Cancer - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Nasopharyngeal Cancer - Pipeline Review, H2 2018’, provides an overview of the Nasopharyngeal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Na...

Leiomyosarcoma - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Leiomyosarcoma - Pipeline Review, H2 2018’, provides an overview of the Leiomyosarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Leiomyosarcoma, ...

Fibrosarcoma - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Fibrosarcoma - Pipeline Review, H2 2018’, provides an overview of the Fibrosarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Fibrosarcoma, comple...

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2018’, provides an overview of the B-Cell Chronic Lymphocytic Leukemia pipeline landscape.

The report provides comprehensive information on the therapeut...

Synovial Sarcoma - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Synovial Sarcoma - Pipeline Review, H2 2018’, provides an overview of the Synovial Sarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Synovial Sar...

Ovarian Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2018’, provides an overview of the Ovarian Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ovarian Cancer, ...

Prostate Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2018’, provides an overview of the Prostate Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Prostate Cance...

Colorectal Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2018’, provides an overview of the Colorectal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Colorectal...

Melanoma - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2018’, provides an overview of the Melanoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Melanoma, complete with anal...

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2018’, provides an overview of the Multiple Myeloma (Kahler Disease) pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2018’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) pipeline landscape.

The report p...

Colon Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2018’, provides an overview of the Colon Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Colon Cancer, comple...

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2018’, provides an overview of the Kidney Cancer (Renal Cell Cancer) pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Non-Small Cell Lung Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2018’, provides an overview of the Non-Small Cell Lung Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Pancreatic Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2018’, provides an overview of the Pancreatic Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pancreatic ...

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2018’, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) pipeline landscape.

The report provides comprehensive information on the therap...

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018’, provides an overview of the Glioblastoma Multiforme (GBM) pipeline landscape.

The report provides comprehensive information on the therapeutics under dev...

Medulloblastoma - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Medulloblastoma - Pipeline Review, H1 2018’, provides an overview of the Medulloblastoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Medulloblastom...

Recurrent Malignant Glioma - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Recurrent Malignant Glioma - Pipeline Review, H1 2018’, provides an overview of the Recurrent Malignant Glioma pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) - Pipeline Review, H1 2018’, provides an overview of the Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) pipeline landscape.

The report provides comprehensive ...

Neuroendocrine Tumors - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neuroendocrine Tumors - Pipeline Review, H1 2018’, provides an overview of the Neuroendocrine Tumors pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ne...

High-Grade Glioma - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘High-Grade Glioma - Pipeline Review, H1 2018’, provides an overview of the High-Grade Glioma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for High-Grade...

Merkel Cell Carcinoma - Pipeline Review, H1 2018

  • $2,000
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Merkel Cell Carcinoma - Pipeline Review, H1 2018’, provides an overview of the Merkel Cell Carcinoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Me...

Bladder Cancer - Pipeline Review, H1 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2018’, provides an overview of the Bladder Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bladder Cancer, ...

Hepatocellular Carcinoma - Pipeline Review, H1 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2018’, provides an overview of the Hepatocellular Carcinoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Neuroblastoma - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Neuroblastoma - Pipeline Review, H1 2018’, provides an overview of the Neuroblastoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Neuroblastoma, com...

Non-Hodgkin Lymphoma - Pipeline Review, H1 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2018’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Non-...

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2018’, provides an overview of the Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) pipeline landscape.

The repo...

Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2018’, provides an overview of the Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

The report provides comprehensive information on the therapeutic...

Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2018’, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) pipeline landscape.

The report pro...

Myelodysplastic Syndrome - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2018’, provides an overview of the Myelodysplastic Syndrome pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Small-Cell Lung Cancer - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2018’, provides an overview of the Small-Cell Lung Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Endometrial Cancer - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Endometrial Cancer - Pipeline Review, H1 2018’, provides an overview of the Endometrial Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Endometr...

Cervical Cancer - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cervical Cancer - Pipeline Review, H1 2018’, provides an overview of the Cervical Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cervical Cance...

Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H1 2018’, provides an overview of the Gastrointestinal Stromal Tumor (GIST) pipeline landscape.

The report provides comprehensive information on the thera...

Ewing Sarcoma - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ewing Sarcoma - Pipeline Review, H1 2018’, provides an overview of the Ewing Sarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ewing Sarcoma, com...

Chondrosarcoma - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Chondrosarcoma - Pipeline Review, H1 2018’, provides an overview of the Chondrosarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Chondrosarcoma, ...

Anaplastic Astrocytoma - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Anaplastic Astrocytoma - Pipeline Review, H1 2018’, provides an overview of the Anaplastic Astrocytoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...

Meningioma - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Meningioma - Pipeline Review, H1 2018’, provides an overview of the Meningioma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Meningioma, complete wit...

Gallbladder Cancer - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gallbladder Cancer - Pipeline Review, H1 2018’, provides an overview of the Gallbladder Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gallblad...

Vaginal Cancer - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Vaginal Cancer - Pipeline Review, H1 2018’, provides an overview of the Vaginal Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Vaginal Cancer, ...

Vulvar Cancer - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Vulvar Cancer - Pipeline Review, H1 2018’, provides an overview of the Vulvar Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Vulvar Cancer, com...

Gliosarcoma - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Gliosarcoma - Pipeline Review, H1 2018’, provides an overview of the Gliosarcoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Gliosarcoma, complete ...

Pontine Glioma - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pontine Glioma - Pipeline Review, H1 2018’, provides an overview of the Pontine Glioma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pontine Glioma, ...

Anaplastic Oligoastrocytoma - Pipeline Review, H1 2018

  • $2,000
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Anaplastic Oligoastrocytoma - Pipeline Review, H1 2018’, provides an overview of the Anaplastic Oligoastrocytoma pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Hepatic - Colorectal Metastasis - Pipeline Review, H2 2017

  • $2,000
  • September 2017
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hepatic - Colorectal Metastasis - Pipeline Review, H2 2017’, provides an overview of the Hepatic - Colorectal Metastasis pipeline landscape.

The report provides comprehensive information on the therapeutics unde...